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Background: Modern flexible multiple daily injection (MDI) therapy requires people with diabetes to manage
complex mathematical calculations to determine insulin doses on a day to day basis. Automated bolus calculators
assist with these calculations, add additional functionality to protect against hypoglycaemia and enhance the record
keeping process, however uptake and use depends on the devices meeting the needs of the user. We aimed to obtain
user feedback on the usability of a mobile phone bolus calculator application in adults with T1DM to inform future
development of mobile phone diabetes support applications.
Methods: Adults with T1DM who had previously received education in flexible MDI therapy were invited to
participate. Eligible respondents attended app education and one month later participated in a focus group to
provide feedback on the features of the app in relation to usability for patient-based flexible MDI and future
app development.
Results: Seven adults participated in the app training and follow up interview. App features that support dose
adjustment to reduce hypoglycaemia risk and features that enable greater efficiency in dose calculation, record
keeping and report generation were highly valued.
Conclusions: Adults who are self managing flexible MDI found the Rapidcalc mobile phone app to be a useful
self-management tool and additional features to further improve usability, such as connectivity with BG meter
and food databases, shortcut options to economise data entry and web based storage of data, were identified.
Further work is needed to ascertain specific features and benefit for those with lower health literacy.
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Self management is the cornerstone of type 1 diabetes
(T1DM) management and patient-based flexible multiple
daily injection (MDI) therapy requires the individual to
perform a number of (often complex) mathematical calcu-
lations [1]. To calculate the prandial insulin dose, the
carbohydrate count must first be calculated for a range of
foods, requiring individuals to interpret carbohydrate data* Correspondence: Brigid.Knight@health.qld.gov.au
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sources. Once the carbohydrate quantity is determined,
the insulin:carbohydrate ratio is then applied, either by
division or multiplication (depending on the method of
carbohydrate counting). Subsequently, a dose correc-
tion is determined by subtracting target blood glucose
(BG) from the prandial BG and dividing by the correc-
tion factor. Numeracy skills are essential for effective
flexible MDI therapy and lower numeracy scores are as-
sociated with lower self-efficacy and higher glycosylated
haemoglobin (HbA1c) [2, 3]. Sussman and colleagues
compared manual insulin dose calculations to an auto-
mated bolus calculator (ABC), and found 63 % of dosele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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compared to 6 % of calculations via an ABC [4].
Automated bolus calculators (ABCs) integrated with
BG meters and insulin pumps have enabled safe and ef-
fective bolus determination as demonstrated by im-
provements in 1) glycaemic control [5–7], 2) treatment
satisfaction [7, 8], and 3) confidence in dose determin-
ation [4, 9] and reduction in 1) frequency [10] and fear
of hypoglycaemia [9], 2) dose calculation errors [4] and
3) treatment burden associated with mathematical cal-
culations and record keeping [11].
In addition to managing the prandial dose calculation,
effective ongoing management of patient-based flexible
MDI therapy requires the person with diabetes to under-
take additional self management tasks which add to the
daily burden of diabetes management. These tasks include
counting carbohydrates (which involves measuring foods,
interpreting food labels, researching unfamiliar foods, per-
forming an estimate of carbohydrate count when eating
out), monitoring blood glucose levels (which involves
washing hands prior to testing, taking care with meter and
test strip handling, remembering to monitor prior to eat-
ing, pre bed, prior to driving and when feeling symptom-
atic with hypoglycaemia), learn the impact of physical
activity and alcohol on blood glucose and make anticipa-
tory adjustments, record BG and additional pertinent dia-
betes management information (such as carbohydrate,
alcohol, activity, stress, illness) in a diabetes diary, and ef-
fectively collaborate with health professionals.
The BG or diabetes diary, which is often paper-based,
is an essential component of flexible MDI, as it enables
comparison to BG targets and enables BG trends to be
analysed to inform proactive changes in insulin formula.
Despite the importance of the BG diary, compliance with
BG diary recording is often poor [12]. Use of an electronic
hand held diary has been shown to improve compliance
with record keeping, compared to the ‘traditional’ paper-
based diary [13] and the combining of dose calculator and
BG diary recording functionality may explain the satisfac-
tion and preference for ABCs [4]. Some ABCs enable
users to record additional pertinent data (such as exercise
and illness), usually in pre-determined text format. Free
text data recording is not available in ABCs.
Integration of bolus calculator functionality into mobile
phones has emerged, in some cases, with SMS messaging
and telemedicine [14]. In addition to the dose calculator
and BG diary functionality of ABCs, mobile phones have
added advantage of ‘connectivity’, enabling more efficient
communication of data with health professionals provid-
ing self management support. Improved motivation, self
management reflection and communication between pa-
tient and health professional has been observed with use
of mobile phone diary apps [15], highlighting the benefits
of this technology in self management support.In Australia, there are over 30 million mobile phones
registered [16], which is more than one per person and
more thank half (68 %) use mobile phone apps [17]. The
ubiquitous nature of mobile phones ensures universal ac-
cess to this technology, potentially enabling a greater num-
ber of individuals to access an ABC with BG diary features.
The RapidCalc mobile phone app was developed locally,
as an adjunctive tool to support a specific subset of adults
with T1DM – those who have been trained in flexible insu-
lin self management using carbohydrate counting and insu-
lin:carbohydrate ratios. The app has been developed
specifically to provide a phone-based platform to support
the following self-management practices: bolus dose deter-
mination (based on individual insulin adjustment algo-
rithms), diabetes diary recording, report generation and
communication with health professionals. The app bolus
calculation equation is consistent with ABCs, with the calcu-
lation for bolus doses determined from three calculations: 1)
bolus for carbohydrate, based on insulin:carbohydrate ratio,
2) correction bolus based on prandial glucose, insulin sensi-
tivity and target BG and 3) insulin on board (IOB) based on
residual insulin from previous bolus dose(s). Rapidcalc also
incorporates the following features, which differentiates it
from ABCs: 1) free text option for recording pertinent de-
tails relating to a specific events, 2) food photograph option,
that enables the user to save a food photograph, time
stamped with the relevant carbohydrate count in the dia-
betes diary, 3) variable options for bolus adjustment for ex-
ercise, 4) ‘Reverse calculator’ which calculates the
carbohydrate required when BG is below target, 5) omission
of correction bolus for high BG due to an antecedent
hypoglycaemic event, or when consuming a significant
quantity of alcohol and 6) data export capabilities via email.
To our knowledge, there are currently no other
phone-based bolus calculator applications which incorp-
orate these features.
The aim of this study was to obtain user feedback on
the usability of the RapidCalc app in adults with T1DM
already experienced in flexible MDI, with a view to
informing further development of this application and
identifying user preferences with this emerging technol-
ogy. We sampled from graduates who had recently
completed structured education in flexible insulin self
management education to explore the specific features
that this specific type of insulin user would want from a




The interview group consisted of 7 participants who had
previously received flexible MDI education program by
attending the Dose Adjustment for Normal Eating
(DAFNE) program. The DAFNE program aims to equip
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skills based on carbohydrate counting and insulin algo-
rithms, and includes insulin adjustment strategies for
physical activity, illness and when consuming alcohol,
and pattern evaluation of BG trends to inform ongoing
insulin adjustment to achieve target glucose levels. Each
DAFNE course is delivered in a group setting, over 5
consecutive days. DAFNE graduates were chosen, firstly,
as they have received the same insulin self-management
education and secondly, because they have had consider-
able experience contributing their opinion alongside
others with T1DM in a group setting. Graduates who
had completed DAFNE education in the most recent
13 months were invited by email to participate. The in-
clusion criteria were: age 18–65 years, access to an
iphone or iPod touch, able to attend a 1-2 h training ses-
sion at study commencement and 1–2 h group interview
at the end of the trial period, willingness to email Rapid-
Calc results to the study centre once per week for the
first four weeks of the study, using insulin Glargine
(Lantus), Insulin Detemir (Levemir) or NPH (Humulin
NPH, protaphane) insulin for basal insulin and Insulin
Glulisine (Apidra), Insulin Lispro (Humalog) or Insulin
Aspart (Novorapid) for bolus insulin, able to inject in-
sulin for all meals and large snacks, able to test BG at
least 4 - 6 times/day, HbA1c 53 - 86 mmol/mol (7–
10 %), absence of end stage diabetes complications or
other serious medical condition except for well man-
aged coeliac disease, thyroid disease or asthma (not re-
quiring oral steroids) and able to read and speak English.
Criteria for exclusion were: hypoglycaemia unawareness,
major psychiatric illness that prevents interaction in a
group setting, pregnancy or breast feeding and use of an
insulin pump.Procedures
Four weeks prior to the app education session, partici-
pants were instructed by phone or email how to load the
app on their phone. Participants were asked to maintain
a paper-based BG diary for 4 weeks, with weekly trans-
mission to the study coordinator. The purpose of this
was to support participants in optimising insulin algo-
rithms prior to app use.App education session
Education on the use of the app was conducted by the
app developer in a group setting with all participants
present. A diabetes educator (BK) was in attendance to
support programming of the app with each user’s exist-
ing insulin dose algorithms. Participants started using
the app following this session. Participants were invited
to contact the diabetes educator (BK) for assistance with
dose adjustment at any time until the focus groupmeeting. One month after app education session, all par-
ticipants were invited to return for the focus group.
The focus group
The focus group was led by a diabetes educator (MN)
who was not involved in development of the app or in
the app education session. The open ended interaction
of a group interview was chosen to stimulate thought
and emotions, to reveal material which may not ordin-
arily be expressed in an individual interview. A semi-
structured interview format was used, focusing on the
attributes of usability, which include learnability, effi-
ciency, memorability, errors and satisfaction [18].
Interview prompts were devised within the research
team, which was comprised of experienced clinicians
and researchers and focus group questions are sum-
marised in Appendix A. The aim was to develop
themes to address the aims of the study without being
deemed leading or judgemental.
At this visit, app data exports (data reports which
show data entered by each user) were obtained for each
participant to identify the duration of app use. The
interview was audio recorded, then transcribed verba-
tim. Thematic analysis of the focus group followed the
structured approach outlined by Braun & Clarke [19]
where themes were identified according to the group
discussion and not limited to the usability attributes.
Themes were coded according to specific app features
to highlight the features that participants found useful
or not. The transcript was reviewed by two reviewers
(BK & MN) independently, who met to address discrep-
ancies and agree on themes.
Results
Fifteen DAFNE graduates were sent an invitation to par-
ticipate and nine graduates expressed interest, however
2 were unable to participate due to scheduling conflicts.
Seven adults (5 female) with mean (SD) age of 36 (7)
years and mean duration of diabetes 27 (7) years,
attended app education and a 2 h focus group. Partici-
pant characteristics are summarised in Table 1. Six of
the seven participants used the app for the duration of
the study period. The one participant who had not used
the app for the duration of the study indicated that she
had failed to sustain regular BG monitoring during the
study, therefore ceased using the app.
Three main themes were identified from the focus
group: 1) bolus calculator features and trust, 2) diabetes
diary and report features and 3) satisfaction and control.
Within each theme, sub-themes are described, with re-
spondent quotes coded according to gender, number
identifier, age category and diabetes duration: for ex-
ample, F5 (A40-44, D20) refers to female number 5,
aged 40–44 years, with 20 years diabetes duration.
Table 1 Participant characteristics
Participant number Age (years) Gender Diabetes duration (years)
1 30–34 F 20
2 30–34 M 26
3 30–34 F 21
4 30–34 M 25
5 30–34 F 27
6 35–39 F 34
7 50–54 F 38
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Users programmed the app with their personal insulin algo-
rithms with the help of the study team and none of the
group reported difficulty in the set up process. Six partici-
pants reported that they trusted the accuracy of the dose
calculation via the app, though five reported they like to
‘check the dose’ recommended by the app, against manual
calculations. One participant (F1, A35-39, D27) rarely
checked the dose, acknowledging that "I'm one of those
people in the population that would go, 'I don't have to
think, just tell me what to have.' “ This person went on to
add that she trusted the app more than her own calcula-
tions, claiming that “ the app is a lot more consistent that I
am” and “It's better than guessing in the complete dark - it's
less dark." She went on to acknowledge that her trust in the
app meant that she didn’t check her ratios (confirm suit-
ability of current dosing algorithms), which she admitted
did not enable ‘fine tuning’ and ongoing dose adjustment.
F5 (A30-34, D25) described how the app made it easier for
her to remember the insulin:carbohydrate ratio to use for
specific meals, especially after a change in prescription for
insulin:carbohydrate ratio.
Four participants described over-riding the dose, not be-
cause of a lack of trust, but for specific reasons, such as
when physically active or when snacking. There was group
agreement with F5 (A30-34, D 25), who reported "It's not
that I don't trust it, it's just that I need to over-ride it." M1
(A30-34, D26) highlighted the problem with the preset
time frames for dose algorithms in the app: "My ratios
didn't fall into time frames provided by the app. I usually
use the 1:1 ratio at lunch and a 2:1 ratio in the evening,
so......if I had a snack in the afternoon, I usually use the
1:1.... but if I have the snack between 4 and 5 (pm) and
that falls within the dinner… so I would be ignoring the
dose that it was calculating because I thought no, that is
twice as much as I want to be having." The 4 participants
who had to override the app due to preset time frames for
the insulin algorithms stated a preference for customisable
time settings for insulin algorithms.
Three participants found the IOB feature useful in redu-
cing the risk of hypoglycaemia. F1 (A35-39, D27) described
this feature as "The best thing in the world." Thoughconsidered useful, many found that the IOB was misleading
when meals and snacks were eaten in close proximity. The
IOB is calculated based on total residual bolus insulin,
therefore may overestimate the IOB in instances where
meals/snacks are eaten in close proximity. Five participants
agreed that they needed to over-ride the bolus suggestion
when meals were consumed in close proximity.
The reverse calculator, which determines the carbohy-
drate to be consumed for BG below target, was used by 4
participants. Two users described specific instances where
this feature protected against hypoglycaemia, or prevented
over-treatment of hypoglycaemia. F3 (A30-34, D21) states,
"What I love… was that it told me how much to have and
I didn't overeat. The number of times that I overeat from
hypos is ridiculous; it would be 99 % of times.” Four par-
ticipants reported that the carbohydrate supplementation
suggestion from the reverse calculator tended to be lower
than their usual guidelines for hypoglycaemia manage-
ment (15 g rapid acting carbohydrate). M2 (A30-34, D26)
was particularly concerned when the app suggested dosing
insulin for some of the hypo treatment: "Cause I found
when I would be 3.4 or 3.3 (mmol/l), the DAFNE rules
would say 1.5 CPs (carbohydrate portions) and I'd put in
1.5 CPs and it would be telling me to take one unit of in-
sulin, which I obviously wasn't going to do.”
The exercise bolus adjustment feature, which can be
programmed to reduce the bolus dose in the setting of
physical activity, had been used by 4 participants. All
agreed that adjusting insulin to manage BGLs around ex-
ercise was challenging. F4 (A30-34, D20) sums up her ex-
perience with the exercise feature, “I don't know how I'm
reacting to exercise because I don't pay enough attention
to it” and F2 (A35-39, D34), "I always muck it up some-
how. I never seem to crack it.” There was general agree-
ment that exercise planning was difficult and that in order
for “any app to work,” each user had to first understand
their own exercise effect and develop management strat-
egies with carbohydrate supplementation and/or insulin
reduction. Two of the group reported that they used the
exercise feature regularly: that it was beneficial and that
the feature served as a prompt to think about changing
bolus doses when they were more physically active than
usual. Three participants agreed that a basal dose adjust-
ment prompt for prolonged exercise would also be helpful
in instances where exercise is of long duration.
The alcohol bolus adjustment feature, which withholds
the correction bolus after alcohol consumption, was
considered by the group as an important feature, how-
ever there was disparity in the quantity of alcohol that
represents the threshold for when this feature should be
chosen. All users agreed that being able to record alco-
hol consumption (even for small quantities, when no
dose change was programmed) was important, to enable
reflection on the effect of alcohol on BG levels.
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determine the bolus dose. The entire group agreed that it
would be beneficial to have a BG meter that could trans-
mit glucose data directly to the app, eliminating the need
to manually enter glucose data into the phone. Responses
to this option were “That would be brilliant”; “I would do
a dance about that one" and "That would be awesome"
emphasize the overwhelming desire for this feature.
Diary report features
There was an overwhelming group consensus that the app
was a ‘great’ record keeping device, due to 1) the conveni-
ence of entering data onto a smart phone and 2) the fact
that participants were rarely without their phone, enabling
“better record keeping” compared to previous diary methods
and other apps that participants had used.
Participants expressed the desire to retrospectively edit
data pertaining to their diabetes management or food con-
sumed. M1 (A30-34, D26) described, "It drives me mad how
you can't put an entry in after (an event) at any time of the
day. Then I don't bother putting it in. You just wouldn't do
it: (you) just forget about it." There was also a consensus that
the ability to record a ‘true’ account of diabetes management
history (using free text options) and record pertinent events
was a valuable feature. Participants raised the idea of a ‘short-
cut’ button to enable easy recording of a pre-determined list
of events, in addition to the current free text option, to rec-
ord what they considered to be pertinent and useful infor-
mation, when later reviewing BG trends. To further
individualise the app, many felt it would be useful to be
able to personalise screen displays by allowing removal (or
cloaking) of features to simplify the user interface.
Three participants found the Rapidcalc method for cre-
ating diabetes diary reports, using a macro to convert raw
data into a diabetes report was difficult, and that not being
able to easily generate this BG diary data for their treating
clinician was a problem. The group agreed that web based
storage of settings and BG diary data would be a more ef-
fective way to manage their diabetes diary, both for their
own reflection and when consulting their health care pro-
vider. Some participants referred to web based storage of
other phone data and that web based storage of the Rapid-
Calc settings on the phone would also be useful to ensure
data safety in the event of loss of device.
There was group agreement on the desire for food
database connectivity, to assist with carbohydrate count-
ing and enable foods consumed to be easily recorded in
the diabetes diary. Some participants suggested that it
would be helpful to ‘register’ favourite foods in the set
up process, enabling favourite foods to be recorded in
the diary via a shortcut menu. Participants also felt that
it was important to capture specific information about
food when reviewing BG trends and some had used the
photograph feature for this purpose.Satisfaction and control
There was group consensus that the app made bolus cal-
culation easier and quicker, with one participant (F1, A35-
39, D27) reporting that "the application worked for me in
that there was less thinking involved" and that BG control
improved from the start of app use. The group agreed that
the app provided an improved means of diabetes record
keeping compared to previous methods. Two participants
also reported improved BG control since using the app.
Three participants, reflected on improved satisfaction,
compared to their experience with other apps. F1 (A35-39,
D27) reported, “I was using another diabetic app and it
wasn't maintainable for me” and F5 (A30-34, D25), “I find
(the app) so user friendly compared to other apps.” M1
(A30-34, D26) reported, "I quite enjoyed using it," and F1
(A35-39, D27), "It has offered me something that nothing
else in my busy-ness and my avoidance has offered me. "
The entire group found the app to be a useful adjunct to
their diabetes management and a number reported they
enjoyed using it.
Discussion
Users of the Rapidcalc app developed a trust in the app
calculation rapidly and described improved efficiency
and efficacy of day to day insulin management compared
to other methods of dose calculation and recording, and
recommendations to further improve usability and re-
duce the burden of management were identified.
The attributes of usability for which the group were able
to give feedback were errors, efficiency and satisfaction. Er-
rors were not detected and trust in the app dose calculation
was determined early due to ‘dose checking’ against manual
calculations, which the users were accustomed to doing
prior to app use. Early establishment of trust in the dose cal-
culation may be due in part also to the way that the compo-
nents of the bolus dose are displayed on the screen,
enabling quick verification of bolus dose components and
total dose. This is in contrast to Shepard and colleagues
[20], who found that pump users did not trust an ABC (the
Personalised Glucose Advisory System) when they could not
determine how the dose was calculated. The issue of over-
riding the app bolus calculator dose highlights the know-
ledge and experience in this cohort to understand other fac-
tors that impact on BG levels and reflects the active role
these users take in the insulin dose adjustment process.
Users who lack the knowledge and experience to confidently
verify bolus insulin doses may not develop trust as readily.
Users commented on the quick and easy access to dose
calculation and diary recording on a device that most
people carry on their person, suggesting greater efficiency
compared to alternative devices, and suggestions were of-
fered to improve efficiency further. Features that could ‘save
time’ and reduce hypoglycaemia risk were valued and the
specific app features identified as useful were IOB, reverse
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based BG diary. Though this was not measured, improved
glycaemic control was also reported by some participants.
Users were able to give feedback on learnability in the
setting of optimal access to health professional support.
With appropriate training, users found the app easy to
learn and use. First time users who do not have health
professional support may struggle with learnability, espe-
cially if they are not familiar with flexible MDI strategies,
such as carbohydrate counting and use of insulin dose
algorithms, as the app requires the user to input specific
insulin algorithms based on carbohydrate counting.
Given that this app advises insulin dosing, it is expected
that users would collaborate with their health profes-
sional in the programming and familiarisation process.
Participants felt that they could not comment on mem-
orability as they had not experienced resuming app use
after a period of discontinuance.
Much of the discussion focused on app features that the
group found useful and how the app could be further im-
proved. The IOB feature is a novel concept for those who
had not used an ABC previously and there was a positive re-
sponse about the benefits of this feature in reducing
hypoglycaemia risk. The reverse calculator was seen to be
beneficial in controlling the tendency to ‘over treat’
hypoglycaemia. Over treatment of hypoglycaemia is a com-
mon practice and impacts negatively on HbA1c [21]. The
discrepancy between ‘usual’ hypoglycaemia management
protocol and the calculation from the app is not surprising,
given that the standard treatment for hypoglycaemia is
based on a low glucose threshold (≤ 3.5 mmol/l) and fixed
quantity of carbohydrate (15 g), whereas the app mathemat-
ically calculates the relative carbohydrate quantity required
to return the BG to target range. This issue is likely to be a
concern with other users as well and highlights the import-
ance of hypoglycaemia management education.
The bolus adjustment feature for exercise and alcohol
were found to be helpful in reducing hypoglycaemia risk
in those who used these features, though users felt that
the threshold for bolus reduction in the setting of alcohol
consumption needs to be individualised. Regarding bolus
modifications for exercise, there was an overwhelming
consensus that BG management around exercise was diffi-
cult and that individual requirements for exercise needed
to be established before being confident to use the app to
modify insulin doses for exercise. Users found that the
exercise and alcohol bolus adjustment features served
as useful prompts to ‘consider’ dose adjustment in the
these settings. Fully adjustable time frames were also
preferred, to enable dose algorithms to be tailored to
individual requirements for meals and snacks. Pre-set
time frames for insulin algorithm settings appeared to
increase the burden of dose determination in individ-
uals who use varied algorithms through the day.The idea of connectivity between the app and food com-
position databases, to enable carbohydrate data to be
sourced and recorded, was favoured by the group: a prefer-
ence that has been demonstrated in other reports [15, 20].
Connectivity with the internet was also favoured by the
group, as a means to enable the diabetes diary data to be
‘securely’ stored and potentially able to be accessed re-
motely by health professionals.
Users placed high value on the diabetes diary and felt
that it should reflect a full and true account (including
retrospective data edit capability) of diabetes management,
confirming that users consider a comprehensive diary to
be a valuable tool in their diabetes management. This de-
sire to retrospectively edit diabetes diary data has also
been reported by Arsand and colleagues [22]. Users felt it
was important to record all data they perceive to be per-
tinent, either by free text or with ‘personalised’ buttons to
‘economise’ data entry. Users of the Personalised Glucose
Advisory system [20] also reported that the bolus calcula-
tor should take into account and record a broad range of
factors affecting BG levels, such as physical activity dur-
ation and intensity, consumption of higher protein and
higher fat meals, hormonal changes relating to the men-
strual cycle, breastfeeding, stress, shift work and alcohol
consumption. The concerns about data safety and having
easy access to diary data lends further support to the im-
portance that users place on diabetes diary data and the
sharing of this information with health care professionals.
Lawton & colleagues [11] voiced the concern that some
users of ABCs will fail to verify bolus doses or reflect on
glycaemic outcomes to inform ongoing insulin dose titra-
tion. This is a valid concern. ‘Dose checking’ did drop off
in this cohort, as seen in the Lawton cohort, however one
would expect this attrition, given that users have con-
firmed that the calculations can be trusted. In this cohort
as well as Lawton’s, individuals were identified who exhib-
ited either a ‘blind trust’ in the bolus calculator, or did not
know how to adjust the insulin algorithms, which is a con-
cern if the algorithms are not optimised. Lawton’s concern
that dependency on the bolus calculator may lead to des-
killing, abandoning diabetes diary reflection and proactive
titration of insulin doses and reliance on the bolus calcula-
tor, leaving users potentially unable to determine doses in
the event of meter failure is also valid and highlights the
importance of ongoing education and support, before and
after the introduction of ABC’s.
A recurring theme across a number of features was the
desire for functionality that reduces the burden of day to
day management: in diabetes diary recording and carbohy-
drate counting, with shortcut buttons and BG meter and
food database connectivity, personalisation of user screens
and easier access to BG diary data. This highlights that role
that ABCs can play to reduce the burden of day to day man-
agement, however care should be taken to ensure that ABCs
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self-management, a process that is difficult to ‘short cut’.
Others have stressed that when ABCs are used, compre-
hensive education in flexible MDI should remain the key
focus of self – management [11, 23], with education and
support on ABC use delivered by health professionals famil-
iar with ABC functionality. Structured education and on-
going support for flexible MDI using an ABC should
include, at the very least, the following: 1) appropriate edu-
cation on patient-based flexible MDI, including carbohy-
drate counting, 2) comprehensive education on
programming and use of the dose calculator, delivered by
health professionals experienced with these devices, 3) pat-
tern evaluation education using the bolus calculator diary
and graphs and 4) regular and ongoing insulin optimisation
support from health professionals experienced in use of
ABCs and a meter failure plan.
Limitations
The main limitation of this study is the small number of
participants and one focus group. We deliberately targeted
adults with T1DM who were managing their diabetes in a
specific way, using advanced skills that require a certain de-
gree of health literacy and self-directed care. Using DAFNE
graduates ensured that all participants had received similar
flexible MDI education, enabling us to focus on the patient
experience with the app in those who have received flexible
MDI self management education. All DAFNE graduates
have experienced nearly 40 h of group interaction and
hence we were confident of the ability of focus group par-
ticipants to not be ‘led’ by others in the group, or for the
group to be dominated by any individual. Despite the small
number of participants, we feel feedback from this focus
group has yielded valuable user experiences on specific app
features in individuals self-managing flexible MDI. We are
not able to comment on the usability of this app other pa-
tient groups, where flexible MDI education has not been
provided, or in those with low health literacy.
The recruitment of DAFNE graduates yielded a cohort
that is more confident with carbohydrate counting and
patient-based insulin adjustment and the trust in the app
calculation and willingness to over-ride the bolus suggestion
for special circumstances observed in this cohort is most
likely enhanced by a familiarity with insulin adjustment ter-
minology and patient-based insulin dose adjustment strat-
egies. The process of confirming the dose calculation and
over-riding a dose based on prior experience may not apply
to users who are not confident with insulin dose adjustment
strategies and this may have an eroding effect on confidence
and willingness to use the app in instances where adequate
education and support are not available.
The focus group participants all had long standing dia-
betes (average 27 years, range 20–38 years), however,
this selection bias is not expected to impact on how theapp may be perceived or used. Those newly diagnosed
with T1DM are taught similar concepts in patient-based
insulin optimisation from diagnosis, hence are also ex-
pected to be able to successfully use the app, providing
insulin algorithms are adjusted as insulin requirements
change during the honeymoon phase.
The short duration of follow up limits the ability to com-
ment about retention or efficacy of this device when it is no
longer novel or resumption of app use after a period of dis-
continuance. Given that the app performs the dual function
of dose calculation and diabetes diary recording and has the
potential to reduce the burden of diabetes management, we
feel that users who are motivated to self-manage patient-
based flexible MDI and maintain a diabetes diary will con-
tinue to use this app in preference to paper-based ap-
proaches and other mobile phone apps currently available.
For those resuming app use after a period of discontinuance,
the ‘help’ screens within the app may assist with memorabil-
ity. The inclusion of pattern recognition software has been
suggested [11] and this may reduce attrition associated sub-
optimal control due to inappropriate insulin algorithms.
Flexible MDI therapy is also taught outside of the
DAFNE program [24–26], and though there are differences
between programs in terms of mode of delivery and course
duration, these programs all address what are considered
to be the ‘core’ elements of insulin self-management educa-
tion, namely, carbohydrate counting, insulin dose algo-
rithms, adjustment for illness and exercise and proactive
dose adjustment of insulin algorithms, and programs gen-
erally require users to manage dose calculations manually
[27]. We feel that the insights from this focus group can be
extrapolated to other patients who have received flexible
MDI education outside of the DAFNE program.
Insulin users with low health literacy may gain as much,
or greater benefit from using a phone app for dose calcula-
tion, to reduce risks associated with dose calculation errors
and improve communication of data with health profes-
sionals. As with this study cohort, care would need to be
taken to ensure that the appropriate carbohydrate counting
education is provided, however modifications to the app,
such as pattern recognition and prompts to contact health
professionals are potential exciting directions for future re-
search with a broader user group.
Conclusions
Overall, users were satisfied and enjoyed using the app to
manage their diabetes and trust in the bolus calculator was
developed relatively quickly. The ability to maintain a true
and complete diabetes diary that enables users to record a
range of factors in daily management is important to adults
with T1DM who are actively engaged in their insulin self-
management. Features such as personalised user screens,
shortcut buttons for data entry, and food database and
meter connectivity, were highly valued for their potential to
Knight et al. BMC Medical Informatics and Decision Making  (2016) 16:119 Page 8 of 9reduce the burden of day to day management. Also favoured
were options to increase accessibility to a full and accurate
account of diabetes management in the diabetes diary that is
easily accessible to users and their health professionals. The
importance of comprehensive education, both in terms of
patient-based insulin dose determination, as well as ongoing
dose titration is not diminished or substituted by use of a
bolus calculator. These devices should be considered
as tools to reduce the burden of flexible MDI and
should supplement sound flexible MDI education.
This focus group has provided valuable insights into
the features of a smart phone-based app that adults
with T1DM feel are important to support effective
patient-based flexible MDI. Longer term follow up of
patient experience and clinical efficacy of mobile
phone apps incorporating these features warrants
further investigation.Appendix A
Focus group questionsQuestions Attribute
Tell me about your experiences using the rapidcalc app
Prompts if needed:
• Challenges
• Benefits of app
Satisfaction
Describe your experience with learning how to use
the app (general question first, then more specifically,…)
Prompts if needed:
• Inputting settings
• Use of help screens
• Using dose calculator
Learnability
Did you feel you could trust the bolus calculator?
Prompts if needed:
• How closely does the application suggested




How does the app influence your efficiency in:
• Dosage calculation?
• BGL diary recording?
• Exercise adjustments?
• BGL diary reflection?
• Communication of your diary with another
person (eg. your health professional)
Efficiency









If you were to have a period of not using the app, do
you think that you can easily pick it up again and
remember how to use it?
Memorability
What would you ask the developers to change?
Given the opportunity to build a new application




Do you plan to continue to use rapidcalc? SatisfactionAbbreviations
ABC: Automated bolus calculator; BG: Blood glucose; CP: Carbohydrate
portion; DAFNE: Dose adjustment for normal eating; HbA1c: glycosylated
Haemoglobin; Hypo: Hypoglycaemia; IOB: Insulin on board; MDI: Multiple
daily injection; T1DM: Type 1 diabetes mellitus
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